Sebastian Boegel
Sebastian Boegel
PostDoc, Bioinformatician, University Hospital Mainz
Bestätigte E-Mail-Adresse bei uni-mainz.de
TitelZitiert vonJahr
Exploiting the mutanome for tumor vaccination
JC Castle, S Kreiter, J Diekmann, M Löwer, N Van de Roemer, J de Graaf, ...
Cancer research 72 (5), 1081-1091, 2012
4362012
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
S Kreiter, M Vormehr, N Van de Roemer, M Diken, M Löwer, J Diekmann, ...
Nature 520 (7549), 692, 2015
4042015
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
JC Castle, M Loewer, S Boegel, J de Graaf, C Bender, AD Tadmor, ...
BMC genomics 15 (1), 190, 2014
1062014
HLA typing from RNA-Seq sequence reads
S Boegel, M Löwer, M Schäfer, T Bukur, J De Graaf, V Boisguérin, ...
Genome medicine 4 (12), 102, 2013
992013
Mutanome directed cancer immunotherapy
M Vormehr, M Diken, S Boegel, S Kreiter, U Sahin
Current opinion in immunology 39, 14-22, 2016
302016
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines
S Boegel, M Löwer, T Bukur, U Sahin, JC Castle
Oncoimmunology 3 (8), e954893, 2014
292014
Mutated tumor alleles are expressed according to their DNA frequency
JC Castle, M Loewer, S Boegel, AD Tadmor, V Boisguerin, J De Graaf, ...
Scientific reports 4, 4743, 2014
182014
Mutanome engineered RNA immunotherapy: towards patient-centered tumor vaccination
M Vormehr, B Schrörs, S Boegel, M Löwer, Ö Türeci, U Sahin
Journal of immunology research 2015, 2015
142015
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression
J Scholtalbers, S Boegel, T Bukur, M Byl, S Goerges, P Sorn, M Loewer, ...
Genome medicine 7 (1), 118, 2015
122015
In silico HLA typing using standard RNA-Seq sequence reads
S Boegel, J Scholtalbers, M Löwer, U Sahin, JC Castle
Molecular Typing of Blood Cell Antigens, 247-258, 2015
92015
MHC class I loaded ligands from breast cancer cell lines: a potential HLA-I-typed antigen collection
DV Rozanov, ND Rozanov, KE Chiotti, A Reddy, PA Wilmarth, LL David, ...
Journal of proteomics 176, 13-23, 2018
52018
HLA and proteasome expression body map
S Boegel, M Löwer, T Bukur, P Sorn, JC Castle, U Sahin
BMC medical genomics 11 (1), 36, 2018
32018
Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
F Foerster, S Boegel, R Heck, G Pickert, N Rüssel, S Rosigkeit, M Bros, ...
Oncoimmunology 7 (4), e1409929, 2018
12018
Genomics Meets Cancer Immunotherapy
JC Castle, S Boegel, T Bukur, V Boisguerin, M Loewer
Cancer Immunotherapy Meets Oncology, 229-236, 2014
12014
In Silico Typing of Classical and Non-classical HLA Alleles from Standard RNA-Seq Reads
S Boegel, T Bukur, JC Castle, U Sahin
HLA Typing, 177-191, 2018
2018
Determination of HLA type and Expression from next Generation sequencing data and the TRON cancer cell line portal
S Boegel, M Loewer, J Scholtalbers, T Bukur, JC Castle, U Sahin
ONCOLOGY RESEARCH AND TREATMENT 41, 205-206, 2018
2018
NK cells of C57BL/6 mice offer stronger protection than NK cells of Balb/c mice in low immunogenic liver metastases
F Foerster, S Boegel, R Heck, M Bros, M Diken, A Tttenberg, E Bockamp, ...
HEPATOLOGY 66, 152A-152A, 2017
2017
Predicting immunogenicity of t cell epitopes
U Sahin, AD Tadmor, JC Castle, S Boegel, M Löwer
US Patent App. 14/787,110, 2016
2016
Abstract A110: Mutant MHC class II epitopes drive therapeutic immune responses to cancer
M Vormehr, S Kreiter, N van de Roemer, M Diken, M Löwer, F Vascotto, ...
Cancer Immunology Research 4 (1 Supplement), A110-A110, 2016
2016
Balb/c und C57/Bl6 Mäuse unterscheiden sich in ihrer Anfälligkeit und Immunantwort auf Lebermetastasen des B16F10 Melanoms
F Foerster, S Strobl, L Kaps, R Heck, S Weng, Y Kim, M Bros, M Diken, ...
Zeitschrift für Gastroenterologie 53 (08), KG114, 2015
2015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20